127 related articles for article (PubMed ID: 38513830)
1. Increased incidence of thyroid, renal, lung, melanoma, bladder, and prostate cancers after diagnosis of primary cutaneous B-cell lymphoma: A Surveillance, Epidemiology, and End Results database analysis.
Banner L; Rohan TZ; Zachian R; Gross T; Yang HY; Joffe D; Porcu P; Nikbakht N
J Am Acad Dermatol; 2024 Jul; 91(1):151-153. PubMed ID: 38513830
[No Abstract] [Full Text] [Related]
2. Non-Small Cell Lung Cancer as a Second Primary Among Patients With Previous Malignancy: Who Is at Risk?
Wu GX; Nelson RA; Kim JY; Raz DJ
Clin Lung Cancer; 2017 Sep; 18(5):543-550.e3. PubMed ID: 28412093
[TBL] [Abstract][Full Text] [Related]
3. Screening for second malignancies in mycosis fungoides: non-Hodgkin lymphoma, Hodgkin lymphoma, lung cancer, bladder cancer and melanoma.
Goyal A; O'Leary D; Goyal K; Rubin N; Janakiram M
J Eur Acad Dermatol Venereol; 2021 Sep; 35(9):1821-1829. PubMed ID: 34013554
[TBL] [Abstract][Full Text] [Related]
4. Risk of Subsequent Primary Kidney Cancer After Another Malignancy: A Population-based Study.
Abdel-Rahman O
Clin Genitourin Cancer; 2017 Oct; 15(5):e747-e754. PubMed ID: 28314541
[TBL] [Abstract][Full Text] [Related]
5. Malignancies diagnosed before and after anal squamous cell carcinomas: A SEER registry analysis.
Jani KS; Lu SE; Murphy JD; Romesser PB; Jethwa KR; Li D; Chundury A; Wu AJ; Hathout L; Hallemeier CL; Jabbour SK
Cancer Med; 2021 Jun; 10(11):3575-3583. PubMed ID: 33960690
[TBL] [Abstract][Full Text] [Related]
6. Scrutiny-Dependent Cancer and Self-fulfilling Risk Factors.
Welch HG; Brawley OW
Ann Intern Med; 2018 Jan; 168(2):143-144. PubMed ID: 29297002
[No Abstract] [Full Text] [Related]
7. Risk of multiple primary cancers in prostate cancer patients in the Detroit metropolitan area: a retrospective cohort study.
Pawlish KS; Schottenfeld D; Severson R; Montie JE
Prostate; 1997 Oct; 33(2):75-86. PubMed ID: 9316648
[TBL] [Abstract][Full Text] [Related]
8. Coupling of prostate and thyroid cancer diagnoses in the United States.
Tomaszewski JJ; Uzzo RG; Egleston B; Corcoran AT; Mehrazin R; Geynisman DM; Ridge JA; Veloski C; Kocher N; Smaldone MC; Kutikov A
Ann Surg Oncol; 2015 Mar; 22(3):1043-9. PubMed ID: 25205302
[TBL] [Abstract][Full Text] [Related]
9. Risk of second primary malignancies following cutaneous melanoma diagnosis: a population-based study.
Spanogle JP; Clarke CA; Aroner S; Swetter SM
J Am Acad Dermatol; 2010 May; 62(5):757-67. PubMed ID: 20223559
[TBL] [Abstract][Full Text] [Related]
10. Cutaneous T-cell lymphoma is associated with increased risk of lymphoma, melanoma, lung cancer, and bladder cancer.
Goyal A; O'Leary D; Goyal K; Patel K; Pearson D; Janakiram M
J Am Acad Dermatol; 2021 Dec; 85(6):1418-1428. PubMed ID: 32822803
[TBL] [Abstract][Full Text] [Related]
11. Subsequent primary cancers among men and women with in situ and invasive melanoma of the skin.
Balamurugan A; Rees JR; Kosary C; Rim SH; Li J; Stewart SL
J Am Acad Dermatol; 2011 Nov; 65(5 Suppl 1):S69-77. PubMed ID: 22018070
[TBL] [Abstract][Full Text] [Related]
12. The risk of bladder cancer in patients diagnosed with other primary neoplasms: analysis of the SEER database.
Anderson JK; Alanee S; Lindgren B; Slaton J
Urol Oncol; 2013 Aug; 31(6):862-5. PubMed ID: 21784673
[TBL] [Abstract][Full Text] [Related]
13. Increased risk of second primary cancers after a diagnosis of melanoma.
Bradford PT; Freedman DM; Goldstein AM; Tucker MA
Arch Dermatol; 2010 Mar; 146(3):265-72. PubMed ID: 20231496
[TBL] [Abstract][Full Text] [Related]
14. Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts.
Huang KP; Weinstock MA; Clarke CA; McMillan A; Hoppe RT; Kim YH
Arch Dermatol; 2007 Jan; 143(1):45-50. PubMed ID: 17224541
[TBL] [Abstract][Full Text] [Related]
15. Other primary systemic cancers in patients with melanoma: Analysis of balanced acral and nonacral melanomas.
Bae SH; Seon HJ; Choi YD; Shim HJ; Lee JB; Yun SJ
J Am Acad Dermatol; 2016 Feb; 74(2):333-40. PubMed ID: 26584878
[TBL] [Abstract][Full Text] [Related]
16. Increasing age and treatment modality are predictors for subsequent diagnosis of bladder cancer following prostate cancer diagnosis.
Singh AK; Mashtare TL; McCloskey SA; Seixas-Mikelus SA; Kim HL; May KS
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1086-94. PubMed ID: 20350797
[TBL] [Abstract][Full Text] [Related]
17. Increased risk of second primary hematologic and solid malignancies in patients with mycosis fungoides: A Surveillance, Epidemiology, and End Results analysis.
Goyal A; O'Leary D; Goyal K; Rubin N; Bohjanen K; Hordinsky M; Chen ST; Pongas G; Duncan LM; Lazaryan A
J Am Acad Dermatol; 2020 Aug; 83(2):404-411. PubMed ID: 31374302
[TBL] [Abstract][Full Text] [Related]
18. Risk Factors for Melanoma Among Survivors of Non-Hodgkin Lymphoma.
Lam CJ; Curtis RE; Dores GM; Engels EA; Caporaso NE; Polliack A; Warren JL; Young HA; Levine PH; Elmi AF; Fraumeni JF; Tucker MA; Morton LM
J Clin Oncol; 2015 Oct; 33(28):3096-104. PubMed ID: 26240221
[TBL] [Abstract][Full Text] [Related]
19. Survival outcomes of secondary cancers in patients with Waldenström macroglobulinemia: An analysis of the SEER database.
Castillo JJ; Olszewski AJ; Kanan S; Meid K; Hunter ZR; Treon SP
Am J Hematol; 2015 Aug; 90(8):696-701. PubMed ID: 25963924
[TBL] [Abstract][Full Text] [Related]
20. Synchronous and antecedent nonthyroidal malignancies in patients with papillary thyroid carcinoma.
Murray SE; Schneider DF; Bauer PS; Sippel RS; Chen H
J Am Coll Surg; 2013 Jun; 216(6):1174-80. PubMed ID: 23522438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
